NCT00004938View on ClinicalTrials.gov

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 1996

Study Completion Date

August 31, 1996

Conditions
Sporotrichosis
Interventions
DRUG

fluconazole

All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00004938 - Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis | Biotech Hunter | Biotech Hunter